Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 316 AL 330

Current and novel therapeutic molecules and targets in Alzheimer's disease

Kumar A, Nisha CM, Silakari C, Sharma I, Anusha K, Gupta N, Nair P, Tripathi T, Kumar A.

J Formos Med Assoc. 2016 Jan;115(1):3-10. doi: 10.1016/j.jfma.2015.04.001. Epub 2015 Jul 26.

Time to Treatment Initiation in People With Alzheimer Disease: A Meta-Analysis of Randomized Controlled Trials

Tsoi KK, Hirai HW, Chan JY, Kwok TC.

J Am Med Dir Assoc. 2016 Jan;17(1):24-30. doi: 10.1016/j.jamda.2015.08.007. Epub 2015 Sep 26.

Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease

Choe YM, Kim KW, Jhoo JH, Ryu SH, Seo EH, Sohn BK, Byun MS, Bak JH, Lee JM, Yun HJ, Han MI, Woo JI, Lee DY.

Int J Geriatr Psychiatry. 2016 Jul;31(7):731-9. doi: 10.1002/gps.4384. Epub 2015 Nov 9.

The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease

Ishikawa I, Shinno H, Ando N, Mori T, Nakamura Y.

Acta Neuropsychiatr. 2016 Jun;28(3):157-64. doi: 10.1017/neu.2015.61. Epub 2015 Nov 17.

Donepezil-associated manic episode with psychotic features: a case report and review of the literature

Hategan A, Bourgeois JA.

Gen Hosp Psychiatry. 2016 Jan-Feb;38:115.e1-4. doi: 10.1016/j.genhosppsych.2015.09.004. Epub 2015 Sep 25.

Memory suppression in Alzheimer's disease

El Haj M.

Neurol Sci. 2016 Mar;37(3):337-43. doi: 10.1007/s10072-015-2441-5. Epub 2015 Dec 23.

Therapeutic strategies for Alzheimer's disease in clinical trials

Godyń J, Jończyk J, Panek D, Malawska B.

Pharmacol Rep. 2016 Feb;68(1):127-38. doi: 10.1016/j.pharep.2015.07.006. Epub 2015 Aug 5.

Functional connectivity increase in the default-mode network of patients with Alzheimer's disease after long-term treatment with Galantamine

Blautzik J, Keeser D, Paolini M, Kirsch V, Berman A, Coates U, Reiser M, Teipel SJ, Meindl T.

Eur Neuropsychopharmacol. 2016 Mar;26(3):602-13. doi: 10.1016/j.euroneuro.2015.12.006. Epub 2015 Dec 10.

A pilot study of a new method of cognitive stimulation using abacus arithmetic in healthy and cognitively impaired elderly subjects

Matías-Guiu JA, Pérez-Martínez DA, Matías-Guiu J.

Neurologia. 2016 Jun;31(5):326-31. doi: 10.1016/j.nrl.2015.02.002. Epub 2015 Apr 1.

Protecting cognition from aging and Alzheimer's disease: a computerized cognitive training combined with reminiscence therapy

Barban F, Annicchiarico R, Pantelopoulos S, Federici A, Perri R, Fadda L, Carlesimo GA, Ricci C, Giuli S, Scalici F, Turchetta CS, Adriano F, Lombardi MG, Zaccarelli C, Cirillo G, Passuti S, Mattarelli P, Lymperopoulou O, Sakka P, Ntanasi E, Moliner R, Garcia-Palacios A, Caltagirone C.

Int J Geriatr Psychiatry. 2016 Apr;31(4):340-8. doi: 10.1002/gps.4328. Epub 2015 Jul 23.

CAP--advancing the evaluation of preclinical Alzheimer disease treatments

Reiman EM, Langbaum JB, Tariot PN, Lopera F, Bateman RJ, Morris JC, Sperling RA, Aisen PS, Roses AD, Welsh-Bohmer KA, Carrillo MC, Weninger S.

Nat Rev Neurol. 2016 Jan;12(1):56-61. doi: 10.1038/nrneurol.2015.177. Epub 2015 Sep 29.

Group and individual cognitive therapies in Alzheimer's disease: the ETNA3 randomized trial

Amieva H, Robert PH, Grandoulier AS, Meillon C, De Rotrou J, Andrieu S, Berr C, Desgranges B, Dubois B, Girtanner C, Joël ME, Lavallart B, Nourhashemi F, Pasquier F, Rainfray M, Touchon J, Chêne G, Dartigues JF.

Int Psychogeriatr. 2016 May;28(5):707-17. doi: 10.1017/S1041610215001830. Epub 2015 Nov 17.

[Effectiveness of occupational therapy and other non-pharmacological therapies in cognitive impairment and Alzheimer's disease]

Matilla-Mora R, Martínez-Piédrola RM, Fernández Huete J; en representación del Grupo de Trabajo de Terapia Ocupacional de la SEGG (GTTO).

Rev Esp Geriatr Gerontol. 2016 Nov-Dec;51(6):349-356. doi: 10.1016/j.regg.2015.10.006. Epub 2015 Nov 21.

Sedation mediates part of Citalopram's effect on agitation in Alzheimer's disease

Newell J, Yesavage JA, Taylor JL, Kraemer HC, Munro CA, Friedman L, Rosenberg PB, Madore M, Chao SZ, Devanand DP, Drye LT, Mintzer JE, Pollock BG, Porsteinsson AP, Schneider LS, Shade DM, Weintraub D, Lyketsos CG, Noda A; CitAD Research Group.

J Psychiatr Res. 2016 Mar;74:17-21. doi: 10.1016/j.jpsychires.2015.12.005. Epub 2015 Dec 12.

Potential of tocotrienols in the prevention and therapy of Alzheimer's disease

Xia W, Mo H.

J Nutr Biochem. 2016 May;31:1-9. doi: 10.1016/j.jnutbio.2015.10.011. Epub 2015 Nov 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias